Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome (Q39725721)

14 September 2017

Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome (English)

1 reference

14 September 2017

0 references

1 reference

4

1 reference

14 September 2017

Lopes C

2

0 references

João Tiago Guimarães

object named as

Guimarães JT

series ordinal

3

0 references

author name string

Santos AC

series ordinal

1

1 reference

PubMed ID

16077717

14 September 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

International Journal of Obesity

14 September 2017

1 reference

14 September 2017

29

1 reference

14 September 2017

1452-1456

1 reference

14 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803035

14 September 2017

0 references

cites work

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein and the risk of developing hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Coming of age of C-reactive protein: using inflammation markers in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Investigating the effect of nonparticipation using a population-based case-control study on myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Is obesity an inflammatory condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Differentiation between obesity and insulin resistance in the association with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Cardiovascular disease risk factors and atherosclerosis in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Effect of alcohol consumption on systemic markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Alcohol consumption and plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

Human blood pressure determination by sphygmomanometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803035

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803035

1 reference

14 September 2017

1 reference

PubMed ID

16077717